For the Inventor, By the Inventor

Enter assignee name

Glycozym Aps

USPTO Granted Patents = 15

% Expired Patents = 73.3

Forward Citations = 59

Loading Chart...

Loading Chart...

10 inventors (with patents filed for the assignee):

Henrik Clausen (15 out of 52 patents)

Tilo Schwientek (7 out of 7 patents)

Eric Bennett (6 out of 9 patents)

4. Rudi Steffensen (2 out of 3 patents)

5. Margarida Amado (2 out of 3 patents)

6. Helle Hassan (1 out of 1 patent)

7. Celso Albuquerque Reis (1 out of 1 patent)

8. Jochen Gätgens (1 out of 1 patent)

9. Detlef Eisenkrätzer (1 out of 1 patent)

10. Frau Helle Hassan (1 out of 1 patent)

15 patents: Sort by Forward Citations

1. 7476527 - [object Object] (2009-01-13),

2. 7449316 - UDP-galactose: β-D-galactose-R 4-α-D-galactosyltransferase, α4Gal-T1 (2008-11-11),

3. 7381554 - UDP-N-acetylglucosamine: galactose-β1,3-N-acetylgalactosamine-α-R/N-acetylglucosamine-β1,3-N-acetylgalactosamine-α-R (GlcNAc to GalNAc) β1,6-N-acetylglucosaminyltransferase, C2/4GnT (2008-06-03),

4. 7374919 - UDP-galactose: β-N-acetyl-glucosamine β-1,4-galactosyltransferase, β4Gal-T2 (2008-05-20),

5. 7338932 - Methods of modulating functions of polypeptide GalNAc-transferases and of screening test substances to find agents herefor, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments (2008-03-04),

6. 7332279 - [object Object] (2008-02-19),

7. 7115404 - UDP-galactose: β-D-galactose-R 4-α-D-galac-tosyltransferase, α4Gal-T1 (2006-10-03),

8. 7097994 - [object Object] (2006-08-29),

9. 7094887 - [object Object] (2006-08-22),

10. 7078206 - UDP-N-acetylglucosamine: galactose-β1,3-N-acetylgalactosamine-α-R/ (GlcNAc to GalNAc) β1,6N-acetylglucosaminyltransferase, C2GnT3 (2006-07-18),

11. 6995004 - UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-β 1,3-N-ACETYLGALACTOSAMINE-α-R / N-ACETYLGLUCOSAMINE-β 1,3,-N-ACETYLGALACTOSAMINE-α-R (GLCNAC TO GALNAC) β1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2/4GNT (2006-02-07),

12. 6916649 - UDP-galactose: β-N-acetyl-glucosamine β-1,4-galactosyltransferase, β4Gal-T2 (2005-07-12),

13. 6794169 - UDP-N-acetylglucosamine: galactose-&bgr;1,3-N-acetylgalactosamine-&agr;-R / (GlcNAc to GalNAc) &bgr;1,6-N-acetylglucosaminyltransferase, C2GnT3 (2004-09-21),

14. 6635461 - UDP-N-acetylglucosamine: galactose-&bgr;1, 3-N-acetylgalactosamine-&agr;-R/(GlcNAc to GalNAc) &bgr;1,6-N-acetylglucosaminyltransferase, C2GnT3 (2003-10-21),

15. 6465220 - Glycosylation using GalNac-T4 transferase (2002-10-15),

GlycoZym ApS is a biotech company specializing in the development of enzyme-based solutions for glycosylation processes. Our innovative enzymatic technology offers efficient, sustainable, and cost-effective solutions for various industries such as pharmaceuticals, food, and cosmetics. With our expertise, we aim to revolutionize glycosylation processes and enable our clients to achieve higher product yields, improved quality, and reduced environmental impact.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

15 Patents

#1 in Holte

#194 in Denmark

#39,846 in the World

Glycozym Aps

Forward Citations = 59

10 inventors:

Henrik Clausen (15 out of 52 patents)

Tilo Schwientek (7 out of 7 patents)

Eric Bennett (6 out of 9 patents)

4. Rudi Steffensen (2 out of 3 patents)

5. Margarida Amado (2 out of 3 patents)

Please report any incorrect information to [email protected]

Loading…